Team:Peking R/HumanPractice/Investigation2

From 2011.igem.org

(Difference between revisions)
 
(2 intermediate revisions not shown)
Line 2: Line 2:
{{https://2011.igem.org/Team:Peking_R/bannerhidden}}
{{https://2011.igem.org/Team:Peking_R/bannerhidden}}
{{https://2011.igem.org/Team:Peking_R/back2}}
{{https://2011.igem.org/Team:Peking_R/back2}}
-
{{https://2011.igem.org/Team:Peking_R/Humanpracticebackground/zmq}}
+
{{https://2011.igem.org/Team:Peking_R/Humanpracticebackground}}
-
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
+
<html xmlns="http://www.w3.org/1999/xhtml">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<head>
Line 286: Line 285:
   <table width="125" height="24" border="0" cellpadding="0" cellspacing="0">
   <table width="125" height="24" border="0" cellpadding="0" cellspacing="0">
     <tr>
     <tr>
-
       <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">Prev</a></th>
+
       <th width="31" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th>
-
       <th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">1</a></th>
+
       <th width="16" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th>
-
       <th width="18" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">2</a></th>
+
       <th width="18" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
-
       <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3/zmq">3</a></th>
+
       <th width="15" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th>
-
       <th width="45" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3/zmq">Next</a></th>
+
       <th width="45" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">Next</a></th>
     </tr>
     </tr>
   </table>
   </table>
Line 297: Line 296:
   <table width="137" height="24" border="0" cellpadding="0" cellspacing="0">
   <table width="137" height="24" border="0" cellpadding="0" cellspacing="0">
     <tr>
     <tr>
-
       <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">Prev</a></th>
+
       <th width="42" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">Prev</a></th>
-
       <th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation/zmq">1</a></th>
+
       <th width="17" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation">1</a></th>
-
       <th width="16" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">2</a></th>
+
       <th width="16" bgcolor="#CCCCCC" class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">2</a></th>
-
       <th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3/zmq">3</a></th>
+
       <th width="18" bgcolor="#E9FEF0" class="clickteam" scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation3">3</a></th>
-
       <th width="44" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2/zmq">Next</a></th>
+
       <th width="44" bgcolor="#E9FEF0"class="clickteam"  scope="col"><a href="https://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2">Next</a></th>
     </tr>
     </tr>
   </table>
   </table>

Latest revision as of 07:23, 5 October 2011

Template:Https://2011.igem.org/Team:Peking R/bannerhidden Template:Https://2011.igem.org/Team:Peking R/back2 Template:Https://2011.igem.org/Team:Peking R/Humanpracticebackground 无标题文档

Investigation of Antibiotic Use and

Related Biosafety Issues: What's

happening out there and further.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Question 5

 

B.Usually discard directly and occasionally process them properly(22.73%)

C.Usually process them properly but occasionally discard directly(21.59%)

D.Always properly process them separately with other waste(23.86%)

E.No special attention has been paid(15.91%)

 

Question 6



Question 8

Question 9

 

 

 


 

Retrieved from "http://2011.igem.org/Team:Peking_R/HumanPractice/Investigation2"